Koers Clal Biotechnology Industries Ltd. TEL AVIV STOCK EXCHANGE
Aandelen
CBI
IL0011042806
Holdingvennootschappen
Omzet 2022 | 370K 101K 92,6K | Omzet 2023 | 104K 28,34K 26,03K | Marktkapitalisatie | 62,27 mln. 16,97 mln. 15,58 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -61 mln. -16,62 mln. -15,27 mln. | Nettowinst (verlies) 2023 | -31 mln. -8,45 mln. -7,76 mln. | EV/omzet 2022 | 331 x |
Nettoschuld 2022 | 23,85 mln. 6,5 mln. 5,97 mln. | Nettoschuld 2023 | 22,4 mln. 6,1 mln. 5,61 mln. | EV/omzet 2023 | 814 x |
K/w-verhouding 2022 |
-1,6
x | K/w-verhouding 2023 |
-2,01
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 34,65% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Assaf Segal
CEO | Chief Executive Officer | 51 | 01-07-15 |
Liat Nissan
DFI | Director of Finance/CFO | 46 | - |
Arnon Aharon
CTO | Chief Tech/Sci/R&D Officer | 55 | 01-01-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 67 | 09-05-03 | |
Yuval Yanai
BRD | Director/Board Member | 71 | 18-11-15 |
Gad Keren
BRD | Director/Board Member | 73 | 17-02-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+21,86% | 83,71 mld. | |
+65,80% | 18,29 mld. | |
+9,95% | 17,75 mld. | |
+11,58% | 15,27 mld. | |
-2,59% | 12,7 mld. | |
+2,81% | 11,49 mld. | |
+3,32% | 10,72 mld. | |
-1,99% | 9,84 mld. | |
+29,27% | 9,78 mld. |